Yahoo India Web Search

Search results

  1. Anthem is committed to the highest standards of quality, compliance, and on-time delivery. Anthem’s culture has gained the trust of partners around the world. Reach Us

    • Careers

      Position: Deputy Manager - I: Qualification: Ph. D in...

    • Contact

      Anthem BioSciences Private limited (Harohalli Unit-II) Plot...

    • Products

      Anthem offers an exclusive product line and technical...

    • About

      Anthem Biosciences is a Contract Research and Innovation...

    • Chemistry

      Screening with Anthem’s proprietary and commercially...

    • Biology

      Anthem’s diverse portfolio of services from early in vitro...

    • Biologics

      Anthem is committed to the highest standards of quality,...

    • Facility 1-Bommasandra

      Anthem Biosciences Bommasandra Final ... Virtual Tour

  2. Anthem Biosciences is a company that offers one stop solution for integrated drug discovery, process development and scale-up. It has facilities in Bommasandra and Horahalli, India, and provides chemistry, biology, gene design, manufacturing and intelligent applications services.

  3. Anthem Biosciences is a Bangalore based Contract Research and Innovation Service Provider (CRISP), located in an Industrial Park in Bangalore with a built-up capacity to house over 500 researchers. Currently, the company employs over 350 people with plenty of room for adding extra capacity.

  4. Jul 9, 2024 · Anthem Biosciences Pvt., a Bengaluru-based contract drug researcher and manufacturer, is considering an initial public offering in India that could raise about $400 million, according to people...

  5. Anthem Biosciences is a CDMO based in Bangalore, India, offering services for pharmaceutical, biotechnology, and specialty chemicals research. See their company profile, updates, employees, and specialties on LinkedIn.

  6. Jul 28, 2024 · Anthem Biosciences has selected JM Financial as the lead banker for its IPO, along with Citi and JP Morgan. The company plans to raise Rs 3,300 crore. Anthem's financials showed a turnover of Rs 1,057 crore and a net profit of Rs 385 crore for the fiscal year ending March 2023.

  7. People also ask

  8. Jul 9, 2024 · Anthem Biosciences Pvt., a Bengaluru-based contract drug researcher and manufacturer, is considering an initial public offering in India that could raise about $400 million, according to people familiar with the matter.

  1. People also search for